High value of the radiobiological parameter D(q) correlates to expression of the transforming growth factor β type II receptor in a panel of small cell lung cancer cell lines

Lung Cancer

Volumn 20, Issue 1, 1998, Pages 65-69

  Hougaard, S ^a   Krarup, M ^b   Norgaard P ^a   Damstrup, L ^a   Spang Thomsen, M ^b   Skovgaard Poulsen, H ^a  

^a FINSEN LABORATORY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cell lines; D(q); DNA repair; Small cell lung cancer; Transforming growth factor , Type II receptor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL DEATH; CONTROLLED STUDY; DNA REPAIR; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; RADIOBIOLOGY;

BLOTTING, NORTHERN; CARCINOMA, SMALL CELL; CELL SURVIVAL; HUMANS; LUNG NEOPLASMS; RADIATION TOLERANCE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REGRESSION ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0031713282     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(98)00013-0     Document Type: Article

References (23)

1. Moss WT, Cox JD. Physical and biologic basis of radiation therapy. Radiation oncology. Rationale, technique, results, The C.V. Mosby Company, 1989:1-58.
2. Joiner MC. Models of radiation cell killing. In: Steel GS, editor. Basic Clinical Radiobiology. London: E. Arnold, 1995:40-47.
3. Peacock J.H., Cassoni A.M., McMillan T.J., Gordon Steel G. Radiosensitive human tumour cell lines may not be recovery deficient. Int J Radiat Biol. 54:1988;945-953.
4. Kaufmann W.K., Paules R.S. DNA damage and cell cycle checkpoints. FASEB J. 10:1996;238-247.
5. Nørgaard P., Hougaard S., Spang-Thomsen M., Poulsen H.S. Transforming growth factor β and cancer. Cancer Treat Rev. 21:1995;367-403.
6. Nørgaard P., Damstrup L., Rygaard K., Spang-Thomsen M., Poulsen H.S. Growth suppression by transforming growth factor-β1 of human small cell lung cancer cell lines is associated to expression of the type II receptor. Br J Cancer. 69:1994;802-808.
7. Inagaki M., Moustakas A., Lin H.Y., Lodish H.F., Carr B.I. Growth inhibition by transforming growth factor β (TGF-β) type 1 is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc Natl Acad Sci USA. 90:1993;5359-5363.
8. Kimchi A., Wang X.-F., Weinberg R.A., Cheifetz S., Massagué J. Absence of TGF-β receptors and growth inhibitory response in retinoblastoma cells. Science. 240:1988;196-199.
9. Geiser A.G., Burmester J.K., Webbink R., Roberts A.B., Sporn M.B. Inhibition of growth by transforming growth factor-β following fusion of two nonresponsive human carcinoma cell lines. J Biol Chem. 267:1992;2588-2593.
10. Krarup M., Poulsen H.S., Spang-Thomsen M. Cellular radiosensitivity of small cell lung cancer cell lines. Int J Radiat Oncol Biol Phys. 38:1997;191-196.
11. Damstrup L., Rygaard K., Spang-Thomsen M., Poulsen H.S. Expression of the transforming growth factor β (TGFβ) receptors and TGF-β1, TGF-β2 and TGF-β3 in human small cell lung cancer cell lines. Br J Cancer. 67:1993;1015-1021.
12. Nørgaard P., Spang-Thomsen M., Poulsen H.S. Expression and autoregulation of transforming growth factor β receptor mRNA in small-cell lung cancer cell lines. Br J Cancer. 73:1996;1037-1043.
13. Potten C.S., Booth D., Haley J.D. Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer. 75:1997;1454-1459.
14. Robson H., Spence K., Anderson E., Potten C.S., Hendry J.H. Differential influence of TGFβ1 and TGFβ3 isoforms on cell cycle kinetics and post-irradiation recovery of normal and malignant colorectal epithelial cells. Int J Radiat Oncol Biol Phys. 38:1997;183-190.
15. Berendsen H.H., De Leij L., De Vries E.G.E., Mesander G., Mulder N.H., De Jong B., Buys C.H.C.M., Postmus P.E., Poppema S., Sluiter H.J., The H.T. Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. Cancer Res. 48:1988;6891-6899.
16. Nørgaard P., Damstrup L., Rygaard K., Spang-Thomsen M., Poulsen H.S. Acquired TGFβ1 sensitivity and TGFβ1 expression in cell lines established from a single small cell lung cancer patient during clinical progression. Lung Cancer. 14:1996;63-73.
17. Anscher M.S., Crocker I.R., Jirtle R.L. Transforming growth factor β1 expression in irradiated liver. Radiat Res. 122:1990;77-85.
18. Anscher M.S., Murase T., Prescott D.M., Marks L.B., Reisenbichler H., Bentel G.C., Spencer D., Sherouse G., Jirtle R.L. Changes in plasma TGFβ levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys. 30:1994;671-676.
19. Barcellos-Hoff M.H. Radiation-induced transforming growth factor β and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res. 53:1993;3880-3886.
20. Anscher M.S., Kong F.-M., Murase T., Jirtle R.L. Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGF-β Br J Radiol. 68:1995;331-333.
21. Markowitz S., Wang J., Myeroff L., Parsons R., Sun L., Lutterbaugh J., Fan R.S., Zborowska E., Kinzler K.W., Vogelstein B., Brattain M., Willson J.K.V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science. 268:1995;1336-1338.
22. 1 arrest, p53, and Rb. Cancer Res. 56:1996;3645-3650.
23. Hougaard S, Nørgaard P, Moses HL, Spang-Thomsen M, Poulsen HS. Mutations of the transforming growth factor β type II receptor in human small cell lung cancer cell lines. AACR Special Conference; Growth Factors, Signalling, and Cancer, 1997 (Abstract).